SAFLF (Safilo Group SpA) Research & Development: $0 Mil (TTM As of Dec. 2025)


SAFLF Safilo Group SpA SAFLF
62 GF Score
Price $2.01
GF Value $1.24
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Safilo Group SpA Research & Development?

Safilo Group SpA SAFLF 62 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates SAFLF with a GF Score™ of 62/100 and a GF Value™ of $1.24 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Safilo Group SpA's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Safilo Group SpA  (OTCPK:SAFLF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Safilo Group SpA Research & Development Related Terms

Safilo Group SpA Research & Development Historical Data

* Premium members only.

The historical data trend for Safilo Group SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Safilo Group SpA Research & Development Chart

Safilo Group SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Safilo Group SpA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAFLF
62GF Score
Safilo Group SpA SAFLF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Safilo Group SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Safilo Group SpA (SAFLF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Safilo Group SpA and its competitors.
Is Safilo Group SpA's Research & Development too high?
Safilo Group SpA's current Research & Development is $0 Mil. Overall, Safilo Group SpA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Research & Development compare to ISRG and BDX?
Safilo Group SpA's Research & Development of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Safilo Group SpA and its competitors. Safilo Group SpA's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.24, compared to a current price of $2.01 — trading 62.1% above its estimated fair value. The current Research & Development is $0 Mil. Safilo Group SpA's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Safilo Group SpA (SAFLF) Overvalued in 2026?

Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued. The current stock price of $2.01 is trading 62.1% above its estimated GF Value™ of $1.24. GuruFocus considers Safilo Group SpA to be Significantly Overvalued.

Key valuation signals for SAFLF:

  • Research & Development: $0 Mil
  • GF Value™: $1.24 vs. price of $2.01 (62.1% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Safilo Group SpA Business Description

Address Settima Strada, 15, Padua, ITA, 35129
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
62GF Score

Get the complete analysis for SAFLF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.01
Price
$1.24
GF Value